EMA Expired: Glybera (alipogene tiparvovec) — uniQure biopharma B.V.

View source ↗

Summary

Glybera (alipogene tiparvovec) has expired status for Hyperlipoproteinemia Type I according to EMA, indicating withdrawal from active regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia Type

Drugs mentioned

• Glybera (alipogene tiparvovec)

Snippet

Status: Expired. Therapeutic area: Hyperlipoproteinemia Type I. MAH: uniQure biopharma B.V.. Decision date: 20/04/2017